{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T05:05:07Z","timestamp":1780463107038,"version":"3.54.1"},"reference-count":101,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:00:00Z","timestamp":1695945600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"the Bill & Melinda Gates Foundation","doi-asserted-by":"crossref","award":["INV-009333"],"award-info":[{"award-number":["INV-009333"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2023,12,31]]},"DOI":"10.1080\/14760584.2023.2263096","type":"journal-article","created":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T12:00:46Z","timestamp":1695643246000},"page":"813-825","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Oral polio vaccine stockpile modeling: insights from recent experience"],"prefix":"10.1080","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0849-9147","authenticated-orcid":false,"given":"Kimberly M.","family":"Thompson","sequence":"first","affiliation":[{"name":"Kid Risk, Inc, Orlando, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominika A.","family":"Kalkowska","sequence":"additional","affiliation":[{"name":"Kid Risk, Inc, Orlando, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4900-9455","authenticated-orcid":false,"given":"Kamran","family":"Badizadegan","sequence":"additional","affiliation":[{"name":"Kid Risk, Inc, Orlando, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,9,29]]},"reference":[{"key":"e_1_3_6_3_1","first-page":"129","article-title":"Stopping a polio outbreak in the post-eradication era","volume":"105","author":"Fine PE","year":"2001","unstructured":"Fine PE, Sutter RW, Orenstein WA. Stopping a polio outbreak in the post-eradication era. Dev Biol (Basel). 2001;105:129\u2013150.","journal-title":"Dev Biol (Basel)"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1540-2487(03)00044-0"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.04.001"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvacx.2021.100119"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.12265"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)70999-5"},{"issue":"5","key":"e_1_3_6_9_1","first-page":"1","article-title":"Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"49","author":"Prevots DR","unstructured":"Prevots DR, Burr RK, Sutter RW, et al. Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. [2000 May 19];49(RR\u20135):1\u201322.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.158.12.1106"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-2358"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1177\/003335491212700104"},{"issue":"25","key":"e_1_3_6_13_1","first-page":"277","article-title":"Polio vaccines: WHO position paper - June 2022","volume":"97","author":"WHO","year":"2022","unstructured":"WHO. Polio vaccines: WHO position paper - June 2022. Weekly Epidemiol Rec. 2022;97(25):277\u2013300.","journal-title":"Weekly Epidemiol Rec"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1539-6924.2012.01864.x"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1539-6924.2006.00827.x"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu184"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.12022"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-020-0176-7"},{"key":"e_1_3_6_19_1","unstructured":"GPEI. GPEI statement on cVDPV2 detections in Burundi and Democratic Republic of the Congo. Geneva (Switzerland): World Health Organization; 2023 [2023 Apr 25]. Available from: https:\/\/polioeradication.org\/news-post\/gpei-statement-on-cvdpv2-detections-in-burundi-and-democratic-republic-of-the-congo\/."},{"issue":"9","key":"e_1_3_6_20_1","first-page":"83","article-title":"Report of the second joint meeting (hybrid) of the WHO global advisory committee on vaccine safety and the WHO advisory committee on safety of medicinal products","volume":"98","author":"WHO","year":"2023","unstructured":"WHO. Report of the second joint meeting (hybrid) of the WHO global advisory committee on vaccine safety and the WHO advisory committee on safety of medicinal products. Wkly Epidemiol Rec. [2022 Dec 14\u201316] Mar 3 2023;98(9):83\u201392.","journal-title":"Wkly Epidemiol Rec"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.18.218370"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.4103\/2224-3151.239418"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(21)00497-6"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix038"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.02.050"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.12688\/gatesopenres.14511.1"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06212-3"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-020-00267-3"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.03.031"},{"key":"e_1_3_6_30_1","unstructured":"WHO. Poliomyelitis: mechanism for management of potetnial risks to eradication. Geneva (Switzerland): World Health Organization; 2008 [cited May 9 2023]. Available from: https:\/\/polioeradication.org\/wp-content\/uploads\/2016\/07\/WHA61_Resolution_English.pdf."},{"key":"e_1_3_6_31_1","unstructured":"WHO. Poliomyelitis. Geneva (Switzerland): World Health Organization; 2015 [cited May 9 2023]. Available from: https:\/\/polioeradication.org\/wp-content\/uploads\/2016\/07\/A68_R3-en.pdf."},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1539-6924.2006.00842.x"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.02.058"},{"key":"e_1_3_6_34_1","unstructured":"GPEI. Responding to a poliovirus outbreak - part 2: protocol for poliovirus type 2. Geneva (Switzerland): World Health Organization; 2017 [cited 2023 May 10]. Available from: https:\/\/polioeradication.org\/wp-content\/uploads\/2018\/01\/pol-sop-responding-polio-event-outbreak-part2-20180117.pdf."},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1114-6"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1465-7"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1322514"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2018.1506333"},{"key":"e_1_3_6_39_1","unstructured":"GPEI. Polio eradication & endgame strategic Plan 2013-2018. Geneva (Switzerland): World Health Organization; 2013 [cited 2023 May 9]. Available from: http:\/\/polioeradication.org\/wp-content\/uploads\/2016\/07\/PEESP_EN_A4.pdf."},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2020.1791093"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.04.026"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.04.061"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.10.060"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.13622"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.13590"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.14158"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.14159"},{"key":"e_1_3_6_48_1","volume-title":"Virtual meeting, 11 October 2022","author":"UNICEF Supply Division","year":"2023","unstructured":"UNICEF Supply Division. Consultation between GPEI and poliovirus vaccine manufacturers, national authorities for containment and national regulatory authorities, Virtual meeting, 11 October 2022. 2023 [cited 2023 Feb 27]]. Available from: https:\/\/polioeradication.org\/wp-content\/uploads\/2023\/01\/Annual-GPEI-Consultation-with-polio-vaccine-manufacturers-NACs-NRAsv-prepublication-version.pdf."},{"key":"#cr-split#-e_1_3_6_49_1.1","unstructured":"World Health Organization. Global OPV stockpile strategy 2022-2026 November 2022. Geneva (Switzerland)"},{"key":"#cr-split#-e_1_3_6_49_1.2","unstructured":"2023 [cited 2023 Aug 10]. https:\/\/polioeradication.org\/wp-content\/uploads\/2023\/06\/Global-OPV-Stockpile-Strategy-31052023.pdf"},{"key":"e_1_3_6_50_1","unstructured":"GPEI. Polio endgame strategy 2019-2023: eradication integration certification and containmen. Geneva (Switzerland): World Health Organization; 2019 [cited 2020 Jun 18]. Available from: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/329948\/WHO-Polio-19.04-eng.pdf."},{"key":"e_1_3_6_51_1","unstructured":"GPEI. Strategy for response to type 2 circulating vaccine-derived poliovirus 2020-2021: An addendum to the polio endgame strategy 2019-2023. Geneva (Switzerland): World Health Organization; 2020 [cited 2020 Mar 10]. Available from: http:\/\/polioeradication.org\/wpcontent\/uploads\/2020\/04\/Strategy-for-the-response-to-type-2-circulating-Vaccine-DerivedPoliovirus-20200406.pdf."},{"key":"e_1_3_6_52_1","unstructured":"GPEI. Delivering on a promise. Polio eradication strategy 2022\u20132026. Geneva (Switzerland): World Health Organization; 2021 [cited 2021 Jun 18]. Available from: https:\/\/polioeradication.org\/wp-content\/uploads\/2021\/06\/polio-eradication-strategy-2022-2026-pre-publication-version-20210609.pdf."},{"key":"e_1_3_6_53_1","unstructured":"GPEI. Library - policy and reports. Geneva (Switzerland): World Health Organization; 2023 [cited 2023 Mar 1]. Available from: https:\/\/polioeradication.org\/library\/."},{"key":"e_1_3_6_54_1","unstructured":"UNICEF. Search. New york (NY): United Nations Children\u2019s Fund; 2023 [cited 2023 Mar 1]. Available from: https:\/\/www.unicef.org\/search."},{"key":"e_1_3_6_55_1","unstructured":"United Nations. World population prospects 2019. (NY): United Nations Department of Economic and Social Affairs Population Division; 2019 [cited 2023 May 9]. Available from: https:\/\/www.un.org\/development\/desa\/pd\/news\/world-population-prospects-2019-0."},{"key":"e_1_3_6_56_1","unstructured":"World Bank. World Bank country and lending groups. Washington DC: The World Bank; 2023 [cited 2023 May 9]. Available from: https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups."},{"key":"e_1_3_6_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvacx.2022.100256"},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir130"},{"key":"e_1_3_6_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.04.037"},{"issue":"8","key":"e_1_3_6_60_1","first-page":"190","article-title":"The case for cooperation in managing and maintaining the end of poliomyelitis: stockpile needs and coordinated OPV cessation","volume":"10","author":"Thompson KM","year":"2008","unstructured":"Thompson KM, Duintjer Tebbens RJ. The case for cooperation in managing and maintaining the end of poliomyelitis: stockpile needs and coordinated OPV cessation. Medscape J Med. 2008;10(8):190.","journal-title":"Medscape J Med"},{"key":"e_1_3_6_61_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1112-8"},{"key":"e_1_3_6_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.13447"},{"key":"e_1_3_6_63_1","unstructured":"UNICEF. Request for proposals - monovalent (Sabin) oral polio vaccine type 2 in bulk form potential conversion into finished product and delivery including the services for storage management and maintenance in a global stockpile. UNICEF Supply Division; 2020 [cited 2023 May 10]. Available from: https:\/\/www.ungm.org\/Public\/Notice\/118260."},{"key":"e_1_3_6_64_1","unstructured":"WHO. Circulating vaccine-derived poliovirus. 2023. Available from: https:\/\/polioeradication.org\/polio-today\/polio-now\/this-week\/circulating-vaccine-derived-poliovirus\/."},{"key":"e_1_3_6_65_1","unstructured":"WHO. Statement of the thirty-sixth meeting of the polio IHR emergency committee. Geneva (Switzerland): World Health Organization; 2023 [cited 2023 Sep 1]. Available from: https:\/\/www.who.int\/news\/item\/25-08-2023-statement-of-the-thirty-sixth-meeting-of-the-polio-ihr-emergency-committee."},{"key":"e_1_3_6_66_1","unstructured":"UNICEF. Vaccine industry consultation 2022: product updates for the portfolio of polio vaccines. UNICEF Supply Division; 2022 [cited 2023 Apr 21]. Available from: https:\/\/www.unicef.org\/supply\/media\/14136\/file\/Portfolio-Polio-products-Ian-Lewis-Jason-Thompson-2022.pdf."},{"key":"e_1_3_6_67_1","unstructured":"GPEI. Delivering on the promise of a polio free world for every child - vaccine industry consultation September 2022. Geneva (Switzerland): Global Polio Eradication Initiative; 2022 [cited 2023 Apr 21]. Available from: https:\/\/www.unicef.org\/supply\/media\/14131\/file\/Programme-Market-Update-Polio-Steven-Lauwerier-2022.pdf."},{"key":"e_1_3_6_68_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw550"},{"key":"e_1_3_6_69_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw571"},{"key":"e_1_3_6_70_1","unstructured":"WHO. 14th meeting of the SAGE polio Working group - Conclusions and recommendations. Geneva (Switzerland): World Health Organization; 2017 [cited 2023 May 10]. Available from: https:\/\/terrance.who.int\/mediacentre\/data\/sage\/SAGE_Docs_Ppt_Oct2017\/5_session_polio\/Oct2019_session5_14th_SAGE_PolioWG.pdf."},{"key":"e_1_3_6_71_1","doi-asserted-by":"publisher","DOI":"10.4172\/2157-7560.1000340"},{"key":"e_1_3_6_72_1","unstructured":"GPEI. Consultation between the GPEI and polio vaccine manufacturers national authorities for containment and national regulatory authorities. Geneva (Switzerland): Global Polio Eradication Initiative; 2022 [cited 2023 SepSep 1]. Available from: https:\/\/polioeradication.org\/wp-content\/uploads\/2023\/04\/Annual-GPEI-Consultation-with-polio-vaccine-manufacturers-NACs-NRAs-V1.2-20220331.pdf"},{"key":"e_1_3_6_73_1","unstructured":"UNICEF. Market supply and update: oral polio vaccine bivalent (bOPV). UNICEF; 2022 [cited 2023 Apr 21]. Available from: https:\/\/www.unicef.org\/supply\/media\/14396\/file\/bOPV-Poster-2022.pdf."},{"key":"e_1_3_6_74_1","unstructured":"GPEI. Consultation between the global polio eradication Initiative and poliovirus vaccine manufacturers national authorities for containment and national regulatory authorities. Geneva (Switzerland): Global Polio Eradication Initiative; 2021 [cited 2023 Apr 21]. Available from: https:\/\/polioeradication.org\/wp-content\/uploads\/2022\/01\/GPEI-Consultation-with-Polio-Vaccine-Manufacturers-NACs-NRAs-2021-v1.0.pdf."},{"key":"e_1_3_6_75_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1115547"},{"key":"e_1_3_6_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(21)00205-9"},{"key":"e_1_3_6_77_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2022.2128108"},{"issue":"1","key":"e_1_3_6_78_1","first-page":"35","article-title":"Global eradication of poliomyelitis: benefit-cost analysis","volume":"74","author":"Bart KJ","year":"1996","unstructured":"Bart KJ, Foulds J, Patriarca P. Global eradication of poliomyelitis: benefit-cost analysis. Bull World Health Organ. 1996;74(1):35\u201345.","journal-title":"Bull World Health Organ"},{"key":"e_1_3_6_79_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199112193252504"},{"key":"e_1_3_6_80_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.13665"},{"key":"e_1_3_6_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2016.08.005"},{"key":"e_1_3_6_82_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa770"},{"key":"e_1_3_6_83_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu128"},{"key":"e_1_3_6_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2006.02.010"},{"key":"e_1_3_6_85_1","unstructured":"GPEI. Consultation with OPV\/IPV manufacturers national authorities for containment and national regulatory authorities. Geneva (Switzerland): Global Polio Eradication Initiative; 2020 [cited 2023 Apr 21]. Available from: https:\/\/polioeradication.org\/wp-content\/uploads\/2022\/01\/2020-GPEI-Consultation-with-OPV-IPV-Manufacturers-NACs-NRAs.pdf."},{"key":"e_1_3_6_86_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.12962"},{"key":"e_1_3_6_87_1","unstructured":"Sharma P. Biological E panacea to make polio vaccine. 2023 [cited 2023 May 11]. Available from: https:\/\/www.livemint.com\/news\/india\/india-prepares-to-produce-and-stockpile-new-polio-vaccine-to-fight-vaccine-derived-polio-virus-outbreaks-globally-11683826896263.html."},{"key":"e_1_3_6_88_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.13664"},{"issue":"22","key":"e_1_3_6_89_1","first-page":"301","article-title":"Meeting of the strategic advisory group of experts on immunization, April 2017 \u2013 conclusions and recommendations","volume":"92","unstructured":"Meeting of the strategic advisory group of experts on immunization, April 2017 \u2013 conclusions and recommendations. Wkly Epidemiol Rec. [2017 Jun 2];92(22):301\u2013320.","journal-title":"Wkly Epidemiol Rec"},{"key":"e_1_3_6_90_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.25407"},{"key":"e_1_3_6_91_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-020-05115-7"},{"key":"e_1_3_6_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2022.100235"},{"key":"e_1_3_6_93_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.13484"},{"key":"e_1_3_6_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.02.060"},{"key":"e_1_3_6_95_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1098419"},{"key":"e_1_3_6_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(23)00116-X"},{"key":"e_1_3_6_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00133-0"},{"key":"e_1_3_6_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00139-1"},{"key":"e_1_3_6_100_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2022-011485"},{"key":"e_1_3_6_101_1","unstructured":"WHO. Global Action Plan for poliovirus containment fourth edition (unedited version). Geneva (Switzerland): World Health Organization; 2022 [cited 2023 Feb 10]. Available from: https:\/\/polioeradication.org\/wp-content\/uploads\/2022\/07\/WHO-Global-Action-Plan-for-Poliovirus-Containment-GAPIV.pdf."},{"key":"e_1_3_6_102_1","doi-asserted-by":"publisher","DOI":"10.2217\/fvl-2018-0079"},{"key":"e_1_3_6_103_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2023.28.5.2300049"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2023.2263096","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T17:34:03Z","timestamp":1701884043000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2023.2263096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,29]]},"references-count":101,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,12,31]]}},"alternative-id":["10.1080\/14760584.2023.2263096"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2023.2263096","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,29]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-06-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}